Venezuela Successfully Applies Cuba’s Abdala COVID-19 Vaccine
In its clinical trials, this Cuban product demonstrated an efficacy of 92.28 percent, which is the fourth highest worldwide.
With the support of the "Mission Into the Neighborhood" social program, Venezuela's health authorities continue to vaccinate the population with Cuba's Abdala COVID-19 vaccine.
RELATED: Cuban COVID-19 Vaccine Abdala Is Over 92% Effective
This product is used in three doses and induces maximum immunity 42 days after the first application. Patients receive the second dose on day 14 and the third one on day 28.
In its clinical trials, this Cuban vaccine demonstrated an efficacy of 92.28 percent, which is the fourth highest worldwide, as explained by BioCubaFarma representative Pedro Almenarez.
Nor has the use of Abdala implied adverse react...










